Fayuvi is authorized for pediatric patients with preserved neurodevelopmental function following a study comparing treated ...

How direct T-cell reprogramming could simplify CAR-T manufacturing, expand patient access, and extend cellular immunotherapy ...

Biopharma is rarely short on scientific promise. But in 2026, the questions facing the industry are increasingly practical: How can complex therapies be developed, manufactured, funded, and ...

What was your biggest professional highlight of the past 12 months? When CCRM was established 15 years ago, we were very forward-thinking in recognizing biomanufacturing as a major gatekeeper of ...

Radiopharmaceuticals are gaining ground in oncology, combining targeted treatment with the delivery of radiation directly to tumors or tumor-associated targets. Yet approval does not guarantee that ...

A mathematician by training, Piers co-founded Hummingbird Bioscience in 2015 to bring rational drug discovery principles to biologics. Drawing on systems biology, immunology, and computational ...

Discover how the right excipient can support efficient processing, reliable dosing, fast dissolution and a more patient-friendly experience, and learn what galenIQ™ brings to modern sachet development ...

Cellares Co-Founder and CEO discusses why the future of cell therapy depends on rethinking how therapies are made ...

For centuries, healers across Africa have relied on medicinal plants to treat everything from infections to chronic conditions. Their knowledge, passed down through generations, remains central to ...

What are the main analytical challenges involved in detecting nitrosamines? Kevin Parker: As with any ultra-low level quantitation experiment, the inherent issue that is always present regards ...

Moderna has announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has authorized its updated COVID-19 mRNA vaccine, Spikevax®, targeting the SARS-CoV-2 LP.8.1 variant, for ...